Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × ipatasertib × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Prostatic Neoplasms 4 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Stomach Neoplasms 1 Skin Diseases 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Multiple Myeloma 1 Lymphoma 1 Fallopian Tube Neoplasms 1 Breast Diseases 1 Advanced Unresectable or Metastatic Solid Malignancy 1

Interventions

Sunitinib 64 Nivolumab 41 pembrolizumab 34 Bevacizumab 32 Everolimus 31 Sorafenib 25 pazopanib 23 Axitinib 23 cabozantinib 13 aldesleukin 13 Ipilimumab 13 temsirolimus 11 Interferon alpha-2 11 Cyclophosphamide 10 avelumab 9 Interleukin-2 9 atezolizumab 8 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 lenvatinib 6 Disulfides 6 fludarabine phosphate 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 Vorinostat 4 Tyrosine Kinase Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡